Our Mission

At SAR Safety Assessment, our mission is to provide clear strategies and solutions to help clients develop new drugs.

We integrate decades of drug development experience with comprehensive toxicology, ADME and pharmacokinetic services to lead clients through all the stages of their preclinical drug development program. SAR Safety Assessment builds bridges across a number of scientific disciplines—preclinical toxicology services, ADME pharmacokinetics and preclinical regulatory strategy—to solve the complexities of 21st century drug development.

Our experience allows us to provide rapid solutions and to address the challenges that can otherwise complicate the preclinical and clinical development of new drugs.

We communicate our advice thoroughly and clearly—for both scientists and non-scientists alike. We realize time is always of the essence and ensure our analysis meets ambitious timelines. We understand the reality of stretched budgets and protect your resources as our own.

When needed, SAR Safety Assessment is incorporates this unique drug metabolism and pharmacokinetics knowledge into comprehensive drug development strategies of clients' drug development.

Our Experience

Stanley A. Roberts, PhD, DABT
Founder and President of SAR Safety Assessment

Having worked in various pharmaceutical settings, directing numerous successful preclinical drug development projects, in 2010 Dr. Roberts decided to build his own consulting business—SAR Safety Assessment.

Prior to establishing SAR Safety Assessment, Dr. Roberts was Vice President of Preclinical Development at CovX Research, LLC where he led the company to three successful IND filings in oncology and one in metabolic disease. Dr. Roberts also worked for Abbott Laboratories for 15 years in toxicology and ADME Pharmacokinetics. Ultimately, he became Global Director of Preclinical Drug Metabolism and Pharmacokinetics.

Dr. Roberts received his PhD in Pharmacology and Toxicology from Purdue University. He is a board certified Diplomate from the American Board of Toxicology. Dr. Roberts is the founding Chairperson of the BIO Pharmacokinetics and Disposition Expert Working Group and is currently an ex officio member of the BioSafe Leadership Committee. He is a member of the Society of Toxicology, the International Society for the Study of Xenobiotics as well as the Southern California Regional Chapter of the Society of Toxicology.